Secondary Attack Rate Measles Vaccine In Second Situation Contacts Cases Confirmed
Clinical trial NCT05592756 · COMPLETED
Trial details
- NCT number
- NCT05592756
- Sponsor
- The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz)
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2020-04-06
- Primary completion
- 2021-08-31
- Enrollment
- 2964
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.